SLB
55
-5
ETN
55
-6
PM
49
-25
INTC
36
-3
PSA
46
-18
WMT
60
-15
SWKS
53
-15
ETR
49
-3
VRSN
43
-20
TJX
65
-4
WDC
63
-3
EA
44
-3
DHI
32
-3
HIG
62
2
ROK
42
-20
T
29
-27
ADP
66
4
WAT
46
-17
DAL
70
-2
KIM
54
3
SLB
55
-5
ETN
55
-6
PM
49
-25
INTC
36
-3
PSA
46
-18
WMT
60
-15
SWKS
53
-15
ETR
49
-3
VRSN
43
-20
TJX
65
-4
WDC
63
-3
EA
44
-3
DHI
32
-3
HIG
62
2
ROK
42
-20
T
29
-27
ADP
66
4
WAT
46
-17
DAL
70
-2
KIM
54
3
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Buy
75

REVS
Columbia Research Enhanced Value ETF

Last Price:
$29.13
Seasonality Move:
1.74%
Buy
57

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$85.70
Seasonality Move:
-32.16%
Buy
75
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $28.76. The Score for REVS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $28.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $88.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.29 Buy
Relative Strength Index (14 RSI): 54.39 Buy
Chaikin Money Flow: -11134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.87 - 28.97) Buy
Bollinger Bands (100): (27.24 - 28.42) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.77 Buy
Relative Strength Index (14 RSI): 66.44 Buy
Chaikin Money Flow: -23974 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.51 - 82.89) Buy
Bollinger Bands (100): (41.26 - 68.88) Buy

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.95 Sell
20-day SMA: 28.53 Buy
50-day SMA: 28.2 Buy
200-day SMA: 26.51 Buy
8-day EMA: 6.39 Buy
20-day EMA: 2.74 Buy
50-day EMA: 1.13 Buy
200-day EMA: 0.29 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.48 Buy
20-day SMA: 74.4 Buy
50-day SMA: 65.57 Buy
200-day SMA: 42.82 Buy
8-day EMA: 85.2 Buy
20-day EMA: 77.09 Buy
50-day EMA: 66.93 Buy
200-day EMA: 47.3 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):